Astellas Pharma Incorporated v Medpro Pharmaceutica (Pty) Ltd and Others (2023/021642)
Astellas Pharma Incorporated v Medpro Pharmaceutica (Pty) Ltd and Others (2023/021642) [2024] ZACCP 1 (26 June 2024)
The court allowed Astellas to amend its mirabegron patent and stayed revocation proceedings, finding Cipla had not proved invalidity, delay, or prejudice.
- Patent Amendment
- Revocation Proceedings
- Culpable Delay
- Inventive Step
- Pharmaceutical Patents
- Patent-amendment